Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Artrya Limited ( (AU:AYA) ) has provided an announcement.
Artrya Limited has announced the quotation of 120,761 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective from September 24, 2025. This move is part of the company’s strategic efforts to enhance its market presence and potentially increase its capital base, which could have significant implications for its growth and stakeholder value.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$3.51 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare industry, focusing on developing and providing advanced medical technology solutions. The company is primarily known for its innovative products aimed at improving cardiovascular health diagnostics and treatment.
Average Trading Volume: 629,441
Technical Sentiment Signal: Buy
Current Market Cap: A$325.2M
Find detailed analytics on AYA stock on TipRanks’ Stock Analysis page.